what are glp 1 agonists America's Poison Centers How GLP-1 Receptor Agonists Evolved
Description
H., He, H., Hickey, G
S2: Peptide Hormones and Growth Factors - New EPO Mimetic Pegmolesatide was added as a new erythropoietin (EPO) mimetic agent
Combination therapies: Manufacturing companies and research organizations are heavily investing in research activities for developing combination therapies such as insulin with GLP-1 RA which can help in improving glycemic control, weight control and also for potential cardiovascular and kidney benefits further providing an individualized approach for patient treatment
doi: 10.1016/S0140-6736(24)01763-X
USA: FDA
